Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for treatment of Netherton Syndrome with LEKTI expressing recombinant microbes

Compositions and methods for treatment of Netherton Syndrome with LEKTI expressing recombinant microbes

US Patent 11773154 · Granted Oct 3, 2023

Estimated economic value: $438,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for treating inflammatory skin disease with recombinant2025
Therapeutic treatment of skin disease with recombinant commensal skin microorgan2024
Therapeutic treatment of skin disease with recombinant commensal skin microorgan2024
Methods and compositions for treating skin disease with recombinant microorganis2023
Auxotrophic strains of staphylococcus bacterium2021
Therapeutic treatment of skin disease with recombinant commensal skin microorgan2020
Therapeutic treatment of skin disease with recombinant commensal skin microorgan2020